Global Neurology Academy

Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
NeuroFrontiers
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
- Clifford Jack Jr., MD
Diagnosing Myasthenia Gravis: The Impact of Social Media
Diagnosing Myasthenia Gravis: The Impact of Social Media
Clinician's Roundtable
Diagnosing Myasthenia Gravis: The Impact of Social Media
- Ashley Baker, MSN, PMHNP
- Vishnu Pandurangadu, MD/MBA, FACEP
- Pritikanta Paul, MD
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
NeuroFrontiers
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
NeuroFrontiers
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
MS Treatment Decisions: When to Discontinue Disease-Modifying Therapies
MS Treatment Decisions: When to Discontinue Disease-Modifying Therapies
NeuroFrontiers
MS Treatment Decisions: When to Discontinue Disease-Modifying Therapies
- Brian P. McDonough, MD, FAAFP
- John Corboy, MD, MA
Personalizing Care Plans for Schizophrenia Patients: Key Factors to Consider
Personalizing Care Plans for Schizophrenia Patients: Key Factors to Consider
NeuroFrontiers
Personalizing Care Plans for Schizophrenia Patients: Key Factors to Consider
- Ashley Baker, MSN, PMHNP
- Desiree Matthews, PMHNP-BC
- Rakesh Jain, MD, MPH
Long-Term Management of Schizophrenia: Preventing Relapse and Promoting Recovery
Long-Term Management of Schizophrenia: Preventing Relapse and Promoting Recovery
NeuroFrontiers
Long-Term Management of Schizophrenia: Preventing Relapse and Promoting Recovery
- Ashley Baker, MSN, PMHNP
- Rakesh Jain, MD, MPH
Continuum of Care: Managing DMD in Pediatric and Adult Patients
Continuum of Care: Managing DMD in Pediatric and Adult Patients
NeuroFrontiers
Continuum of Care: Managing DMD in Pediatric and Adult Patients
- John F. Brandsema, MD

Medical News

Medical News
AI-Driven Tool Offers Contactless Screening for Hypertension and Diabetes
newsroom.heart.org
11/20/2024
Read more
Medical News
Digital Health Technologies Drive Advances in Diabetes Prevention and Management
pbrc.edu
11/20/2024
Read more
Medical News
Patient-Initiated Telemedicine Follow-Up Reduces Healthcare Visits in Spondyloarthritis Management
emjreviews.com
11/20/2024
Read more
Medical News
Engineers Develop Non-Invasive Glucose Monitoring System Using Miniaturized Radar Technology
uwaterloo.ca
11/19/2024
Read more

See more news

CME/CE

Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
CME/CE
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
1.00 credit
- Michael Erdman, PharmD, BCCCP
- Ali A. Habib, MD
1.00 credit
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
CME/CE
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
1.00 credit
- Perry Shieh, MD, PhD
1.00 credit
ATTRv-PN: A Family Affair?
ATTRv-PN: A Family Affair?
MinuteCE®
ATTRv-PN: A Family Affair?
1.00 program credit
- John Berk, MD
- Noel Dasgupta, MD, FACC
1.00 program credit
ATTRv-PN: A Complicated Disease With a Poor Prognosis
ATTRv-PN: A Complicated Disease With a Poor Prognosis
MinuteCE®
ATTRv-PN: A Complicated Disease With a Poor Prognosis
1.00 program credit
- John Berk, MD
- Sami Khella, MD
1.00 program credit

Clinical Practice

Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
NeuroFrontiers
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
- Clifford Jack Jr., MD
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
NeuroFrontiers
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
- Ashley Baker, MSN, PMHNP
- Suzanne Schindler, MD
Unraveling Schizophrenia: Neurobiological and Genetic Factors to Consider
Unraveling Schizophrenia: Neurobiological and Genetic Factors to Consider
NeuroFrontiers
Unraveling Schizophrenia: Neurobiological and Genetic Factors to Consider
- Ashley Baker, MSN, PMHNP
- Greg Mattingly, MD
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
NeuroFrontiers
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
- John F. Brandsema, MD

Programs

Bridging the Gap to Improved Schizophrenia Treatment Options
Bridging the Gap to Improved Schizophrenia Treatment Options
NeuroFrontiers
Bridging the Gap to Improved Schizophrenia Treatment Options
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
NeuroFrontiers
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
- Charles Turck, PharmD, BCPS, BCCCP
- John F. Brandsema, MD
The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
NeuroFrontiers
The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
- Charles Turck, PharmD, BCPS, BCCCP
- Dr. Robert J. Shmookler Reis, PhD
- Dr. Srinivas Ayyadevara, PhD
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
NeuroFrontiers
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
- Ashley Baker, MSN, PMHNP
- Istvan Mody, PhD